– Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) –
– Data presented in a platform session at the Annual Meeting of the American Academy of Neurology in Denver, Colorado –
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously under appreciated role for B cells in vaccine protection. Best known for producing antibodies, B cells also guide other immune cells, […]
While the hit TV show “The Last of Us” depicts a fictional fungus, there is a real fungus causing concern in the healthcare community, and it can be deadly. Click here to view original post
Privacy Updates for Marketing Activation provides ongoing state-by-state legal intelligence connecting legislation, regulation, enforcement, and case law to healthcare advertising and commercialization. BOULDER, Colo., Aug. 19, 2026 /PRNewswire/ — BranchLab today announced the launch of… […]
Copyright © 2026 Biotech Networks
